ATE376020T1 - Verfahren zu herstellung von aktivierten polyethylenglykolen - Google Patents
Verfahren zu herstellung von aktivierten polyethylenglykolenInfo
- Publication number
- ATE376020T1 ATE376020T1 AT02758000T AT02758000T ATE376020T1 AT E376020 T1 ATE376020 T1 AT E376020T1 AT 02758000 T AT02758000 T AT 02758000T AT 02758000 T AT02758000 T AT 02758000T AT E376020 T1 ATE376020 T1 AT E376020T1
- Authority
- AT
- Austria
- Prior art keywords
- polyethylene glycols
- activated polyethylene
- producing activated
- sup
- npc
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2203/00—Applications
- C08L2203/02—Applications for biomedical use
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Polyethers (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31380101P | 2001-08-22 | 2001-08-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE376020T1 true ATE376020T1 (de) | 2007-11-15 |
Family
ID=23217202
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02758000T ATE376020T1 (de) | 2001-08-22 | 2002-08-22 | Verfahren zu herstellung von aktivierten polyethylenglykolen |
Country Status (6)
Country | Link |
---|---|
US (1) | US7125558B2 (de) |
EP (1) | EP1419191B1 (de) |
AT (1) | ATE376020T1 (de) |
CA (1) | CA2457876C (de) |
DE (1) | DE60223047T2 (de) |
WO (1) | WO2003018665A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60214145T2 (de) * | 2001-03-08 | 2007-07-12 | Bioartificial Gel Technologies Inc., Montreal | An einer rückschicht gebundenes hydrogel und verfahren zur herstellung |
WO2003018665A1 (en) | 2001-08-22 | 2003-03-06 | Bioartificial Gel Technologies Inc. | Process for the preparation of activated polyethylene glycols |
EP1680148A1 (de) * | 2003-10-21 | 2006-07-19 | Bioartificial Gel Technologies Inc. | Hydrogel enthaltende medizinische artikel und verfahren zu ihrer herstellung und verwendung |
US7351787B2 (en) * | 2004-03-05 | 2008-04-01 | Bioartificial Gel Technologies, Inc. | Process for the preparation of activated polyethylene glycols |
EP1865920A1 (de) * | 2005-04-04 | 2007-12-19 | Bioartificial Gel Technologies Inc. | Verhütung und behandlung von strahlenbedingter dermatitis |
EP1865982A1 (de) * | 2005-04-06 | 2007-12-19 | Bioartificial Gel Technologies Inc. | Hydrogel-zusammensetzung zur modulierung der topischen entzündungsantwort |
WO2007068086A1 (en) * | 2005-12-05 | 2007-06-21 | Bioartificial Gel Technologies Inc. | Emulsion-containing medical articles |
Family Cites Families (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3463862A (en) | 1964-05-21 | 1969-08-26 | Geneva Carol Mazza | Albumin containing comsmetic lotion |
US4464468A (en) | 1968-03-29 | 1984-08-07 | Agence Nationale De Valorisation De La Recherche (Anvar) | Immobilization of active protein by cross-linking to inactive protein |
US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
IL47468A (en) | 1975-06-12 | 1979-05-31 | Rehovot Res Prod | Process for the cross-linking of proteins using water soluble cross-linking agents |
US4002531A (en) | 1976-01-22 | 1977-01-11 | Pierce Chemical Company | Modifying enzymes with polyethylene glycol and product produced thereby |
CH625702A5 (de) | 1977-01-18 | 1981-10-15 | Delalande Sa | |
US4264155A (en) | 1979-07-09 | 1981-04-28 | Opticol Corporation | Collagen contact lens |
USRE33997E (en) | 1981-02-09 | 1992-07-14 | Allergan, Inc. | Biologically stabilized compositions comprising collagen as the minor component with ethylenically unsaturated compounds used as contact lenses |
US4388428A (en) | 1981-07-20 | 1983-06-14 | National Patent Development Corporation | Biologically stabilized compositions comprising collagen as the major component with ethylenically unsaturated compounds used as contact lenses |
FR2565160B1 (fr) | 1984-06-04 | 1987-03-06 | Essilor Int | Procede pour la realisation d'une lentille de contact souple en polymere(s) proteique(s) naturel(s), et lentille de contact ainsi obtenue |
US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
US4752627A (en) | 1986-08-13 | 1988-06-21 | Michael Froix | Clouding-resistant contact lens compositions |
US5114627A (en) | 1986-10-16 | 1992-05-19 | Cbs Lens | Method for producing a collagen hydrogel |
WO1988006457A1 (en) | 1987-03-04 | 1988-09-07 | Nippon Hypox Laboratories Incorporated | Medicinal composition containing albumin as carrier and process for its preparation |
FR2617763B1 (fr) | 1987-07-07 | 1989-12-01 | Essilor Int | Procede de fabrication de lentille de contact en un polymere proteique naturel, par moulage avant reticulation |
MX12394A (es) | 1987-07-23 | 1993-12-01 | Ciba Geigy Ag | Procedimiento par la obtencion de carbamatos de polietilenglicol. |
US5214131A (en) | 1988-05-06 | 1993-05-25 | Sumitomo Pharmaceuticals Company, Limited | Polyethylene glycol derivatives, modified peptides and production thereof |
US5122614A (en) | 1989-04-19 | 1992-06-16 | Enzon, Inc. | Active carbonates of polyalkylene oxides for modification of polypeptides |
US5324844A (en) | 1989-04-19 | 1994-06-28 | Enzon, Inc. | Active carbonates of polyalkylene oxides for modification of polypeptides |
US5342940A (en) | 1989-05-27 | 1994-08-30 | Sumitomo Pharmaceuticals Company, Limited | Polyethylene glycol derivatives, process for preparing the same |
US5286637A (en) | 1989-08-07 | 1994-02-15 | Debiopharm, S.A. | Biologically active drug polymer derivatives and method for preparing same |
US5039540A (en) | 1989-08-14 | 1991-08-13 | Neophore Technologies, Inc. | Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs |
US5079018A (en) | 1989-08-14 | 1992-01-07 | Neophore Technologies, Inc. | Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs |
JP3051145B2 (ja) | 1990-08-28 | 2000-06-12 | 住友製薬株式会社 | 新規なポリエチレングリコール誘導体修飾ペプチド |
US5545698A (en) | 1990-08-31 | 1996-08-13 | University Of Minnesota | Polyethylene glycol derivatives for solid-phase applications |
US5235028A (en) | 1990-08-31 | 1993-08-10 | University Of Minnesota | Polyethylene glycol derivatives for solid-phase applications |
US5229366A (en) | 1990-10-23 | 1993-07-20 | Fuji Photo Film Co., Ltd. | Peptide-containing polyethylene glycol derivatives and application thereof |
US5252714A (en) | 1990-11-28 | 1993-10-12 | The University Of Alabama In Huntsville | Preparation and use of polyethylene glycol propionaldehyde |
US5595732A (en) | 1991-03-25 | 1997-01-21 | Hoffmann-La Roche Inc. | Polyethylene-protein conjugates |
US5281698A (en) * | 1991-07-23 | 1994-01-25 | Cetus Oncology Corporation | Preparation of an activated polymer ester for protein conjugation |
IT1260468B (it) | 1992-01-29 | 1996-04-09 | Metodo per mantenere l'attivita' di enzimi proteolitici modificati con polietilenglicole | |
US5284974A (en) | 1992-08-11 | 1994-02-08 | Monsanto Company | Process for the preparation of thioacetamide |
US5382657A (en) | 1992-08-26 | 1995-01-17 | Hoffmann-La Roche Inc. | Peg-interferon conjugates |
US5298643A (en) | 1992-12-22 | 1994-03-29 | Enzon, Inc. | Aryl imidate activated polyalkylene oxides |
US5349001A (en) | 1993-01-19 | 1994-09-20 | Enzon, Inc. | Cyclic imide thione activated polyalkylene oxides |
JP3351476B2 (ja) | 1993-01-22 | 2002-11-25 | 三菱化学株式会社 | リン脂質誘導体及びそれを含有するリポソーム |
US5321095A (en) | 1993-02-02 | 1994-06-14 | Enzon, Inc. | Azlactone activated polyalkylene oxides |
US5298410A (en) | 1993-02-25 | 1994-03-29 | Sterling Winthrop Inc. | Lyophilized formulation of polyethylene oxide modified proteins with increased shelf-life |
US5605976A (en) | 1995-05-15 | 1997-02-25 | Enzon, Inc. | Method of preparing polyalkylene oxide carboxylic acids |
US5643575A (en) | 1993-10-27 | 1997-07-01 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
US5446090A (en) | 1993-11-12 | 1995-08-29 | Shearwater Polymers, Inc. | Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
WO1995015352A1 (en) | 1993-12-01 | 1995-06-08 | Universite Du Quebec A Montreal | Albumin based hydrogel |
US5650234A (en) * | 1994-09-09 | 1997-07-22 | Surface Engineering Technologies, Division Of Innerdyne, Inc. | Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces |
US5932462A (en) | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
PT852243E (pt) | 1995-04-14 | 2003-03-31 | Kazunori Kataoka | Polioxido de etileno tendo um residuo de um sacarideo numa das extremidades e um grupo funcional diferente na outra extremidade e processo para a producao do mesmo |
US6214966B1 (en) | 1996-09-26 | 2001-04-10 | Shearwater Corporation | Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution |
WO1999057155A1 (en) | 1998-05-01 | 1999-11-11 | The Procter & Gamble Company | Laundry detergent and/or fabric care compositions comprising a modified antimicrobial protein |
DE19903655A1 (de) | 1999-01-29 | 2000-08-10 | Beiersdorf Ag | Proteinhaltige Hydrogele |
US6348558B1 (en) * | 1999-12-10 | 2002-02-19 | Shearwater Corporation | Hydrolytically degradable polymers and hydrogels made therefrom |
DK1280849T3 (da) | 2000-04-04 | 2007-01-08 | Bioartificial Gel Technologies Inc | Fremgangsmåde til fremstilling af proteinbaserede hydrogeler |
DE60214145T2 (de) | 2001-03-08 | 2007-07-12 | Bioartificial Gel Technologies Inc., Montreal | An einer rückschicht gebundenes hydrogel und verfahren zur herstellung |
AU2002258913A1 (en) * | 2001-04-23 | 2002-11-05 | Wisconsin Alumni Research Foundation | Bifunctional-modified hydrogels |
WO2003018665A1 (en) | 2001-08-22 | 2003-03-06 | Bioartificial Gel Technologies Inc. | Process for the preparation of activated polyethylene glycols |
-
2002
- 2002-08-22 WO PCT/CA2002/001306 patent/WO2003018665A1/en active IP Right Grant
- 2002-08-22 AT AT02758000T patent/ATE376020T1/de not_active IP Right Cessation
- 2002-08-22 US US10/487,392 patent/US7125558B2/en not_active Expired - Lifetime
- 2002-08-22 DE DE60223047T patent/DE60223047T2/de not_active Expired - Lifetime
- 2002-08-22 EP EP02758000A patent/EP1419191B1/de not_active Expired - Lifetime
- 2002-08-22 CA CA2457876A patent/CA2457876C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE60223047T2 (de) | 2008-07-24 |
CA2457876C (en) | 2011-10-11 |
DE60223047D1 (de) | 2007-11-29 |
EP1419191A1 (de) | 2004-05-19 |
WO2003018665A1 (en) | 2003-03-06 |
EP1419191B1 (de) | 2007-10-17 |
US20050080206A1 (en) | 2005-04-14 |
CA2457876A1 (en) | 2003-03-06 |
US7125558B2 (en) | 2006-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20041459L (no) | Kopolymerer for gelatinering av syrer | |
HUP0105077A2 (hu) | Szerin-proteáz inhibitorok és ezeket tartalmazó gyógyszerkészítmények | |
DE50013960D1 (de) | Verfahren zur Herstellung von Acetylen und Synthesegas | |
WO1998014164A3 (de) | Verwendung wasserlöslicher copolymere als wirkstoffe in kosmetischen formulierungen | |
NO20062092L (no) | Nye fremgangsmater for fremstilling av N-desmetylzopiklon og optisk rent (+)-N-desmetylzopiklon og optisk rent (-)-N-desmetylzopiklon | |
ATE416157T1 (de) | Inhibitoren von integrin alpha-v-beta-6 | |
ATE376020T1 (de) | Verfahren zu herstellung von aktivierten polyethylenglykolen | |
CO4700452A1 (es) | Derivados de indol | |
HUP0302193A2 (hu) | 1,4-Diazabiciklo[3.2.2]nonán-benzoxazol,-benzotiazol és -benzimidazol-származékok, előállításuk és ezeket tartalmazó gyógyszerkészítmények | |
NO995431D0 (no) | Substituerte 3,3-diamino-2-propennitriler, deres fremstilling og anvendelse | |
CY1105345T1 (el) | Φαινυλαλκινια | |
DE60113277T2 (de) | Verfahren zur herstellung von dicarbonsäurediarylestern | |
ATE380173T1 (de) | Verfahren zur herstellung von (2s,3r,4s)-4- hydroxyisoleucin und analoga | |
DE50100698D1 (de) | Verfahren zur Herstellung von 1,3,6-Hexantricarbonitril | |
WO2001060822A8 (fr) | Derives d'aminoacides et leur utilisation en tant qu'inhibiteurs de la nep, l'ace et l'ece | |
DE59404784D1 (de) | Neue carbonsäureester von 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purin, deren herstellung sowie deren verwendung | |
DE59810863D1 (de) | Verfahren zur Herstellung von 4-(4-(4-(Hydroxydiphenyl)-1-piperidinyl)-1-hydroxybutyl)-alpha,alpha-dimenthylphenylessigsäure und phosphorylierter Derivate | |
ATE244706T1 (de) | Enantiomere von mercaptolactonen und verfahren zu ihrer herstellung | |
DE50105413D1 (de) | Verfahren zur Racemisierung von optisch aktiven Aminen | |
ATE267788T1 (de) | Verfahren zur wärmenutzung bei der herstellung von 1,2-dichlorethan | |
ATE338026T1 (de) | 4-cyano-3-hydroxy-butanoyl hydrazine, derivate und verfahren zu ihrer herstellung | |
ATE249450T1 (de) | Verfahren zur herstellung von l-ascorbinsäure | |
DE69707603D1 (de) | Verfahren zur Herstellung von N2-Arylsulfonyl-L-Argininamiden | |
DE50214965D1 (de) | Reaktive azofarbstoffe, verfahren zu ihrer herstellung und ihre verwendung | |
TR199801683A2 (xx) | Yeni �re t�revleri. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |